169 related articles for article (PubMed ID: 36344258)
1. Malignant undifferentiated epithelioid neoplasms with MAML2 rearrangements: A clinicopathologic study of seven cases demonstrating a heterogenous entity.
Dermawan JK; DiNapoli SE; Sukhadia P; Mullaney KA; Gladdy R; Healey JH; Agaimy A; Cleven AH; Suurmeijer AJH; Dickson BC; Antonescu CR
Genes Chromosomes Cancer; 2023 Apr; 62(4):191-201. PubMed ID: 36344258
[TBL] [Abstract][Full Text] [Related]
2. Recurrent YAP1::MAML2 fusions in "nodular necrotizing" variants of myxoinflammatory fibroblastic sarcoma: a comprehensive study of 7 cases.
Perret R; Tallegas M; Velasco V; Soubeyran I; Coindre JM; Azmani R; Baud J; Bacle G; De Pinieux G; Le Loarer F
Mod Pathol; 2022 Oct; 35(10):1398-1404. PubMed ID: 35546636
[TBL] [Abstract][Full Text] [Related]
3. Recurrent BRAF Gene Rearrangements in Myxoinflammatory Fibroblastic Sarcomas, but Not Hemosiderotic Fibrolipomatous Tumors.
Kao YC; Ranucci V; Zhang L; Sung YS; Athanasian EA; Swanson D; Dickson BC; Antonescu CR
Am J Surg Pathol; 2017 Nov; 41(11):1456-1465. PubMed ID: 28692601
[TBL] [Abstract][Full Text] [Related]
4. Recurrent YAP1 and MAML2 Gene Rearrangements in Retiform and Composite Hemangioendothelioma.
Antonescu CR; Dickson BC; Sung YS; Zhang L; Suurmeijer AJH; Stenzinger A; Mechtersheimer G; Fletcher CDM
Am J Surg Pathol; 2020 Dec; 44(12):1677-1684. PubMed ID: 32991341
[TBL] [Abstract][Full Text] [Related]
5. Recurrent YAP1 and KMT2A Gene Rearrangements in a Subset of MUC4-negative Sclerosing Epithelioid Fibrosarcoma.
Kao YC; Lee JC; Zhang L; Sung YS; Swanson D; Hsieh TH; Liu YR; Agaram NP; Huang HY; Dickson BC; Antonescu CR
Am J Surg Pathol; 2020 Mar; 44(3):368-377. PubMed ID: 31592798
[TBL] [Abstract][Full Text] [Related]
6. Variant WWTR1 gene fusions in epithelioid hemangioendothelioma-A genetic subset associated with cardiac involvement.
Suurmeijer AJH; Dickson BC; Swanson D; Sung YS; Zhang L; Antonescu CR
Genes Chromosomes Cancer; 2020 Jul; 59(7):389-395. PubMed ID: 32170768
[TBL] [Abstract][Full Text] [Related]
7. Pan-sarcoma genomic analysis of KMT2A rearrangements reveals distinct subtypes defined by YAP1-KMT2A-YAP1 and VIM-KMT2A fusions.
Massoth LR; Hung YP; Nardi V; Nielsen GP; Hasserjian RP; Louissaint A; Fisch AS; Deshpande V; Zukerberg LR; Lennerz JK; Selig M; Glomski K; Patel PJ; Williams KJ; Sokol ES; Alexander BM; Vergilio JA; Ross JS; Pavlick DC; Chebib I; Williams EA
Mod Pathol; 2020 Nov; 33(11):2307-2317. PubMed ID: 32461620
[TBL] [Abstract][Full Text] [Related]
8. Expanding the spectrum of mesenchymal neoplasms with NR1D1-rearrangement.
Lacambra MD; Antonescu CR; Chow C; Chiu WK; Demicco EG; Ferguson PC; Swanson D; To KF; Zhang L; Dickson BC
Genes Chromosomes Cancer; 2022 Jul; 61(7):420-426. PubMed ID: 35168293
[TBL] [Abstract][Full Text] [Related]
9. Recurrent Fusions Between YAP1 and KMT2A in Morphologically Distinct Neoplasms Within the Spectrum of Low-grade Fibromyxoid Sarcoma and Sclerosing Epithelioid Fibrosarcoma.
Puls F; Agaimy A; Flucke U; Mentzel T; Sumathi VP; Ploegmakers M; Stoehr R; Kindblom LG; Hansson M; Sydow S; Arbajian E; Mertens F
Am J Surg Pathol; 2020 May; 44(5):594-606. PubMed ID: 31913156
[TBL] [Abstract][Full Text] [Related]
10. TGFBR3 and MGEA5 rearrangements are much more common in "hybrid" hemosiderotic fibrolipomatous tumor-myxoinflammatory fibroblastic sarcomas than in classical myxoinflammatory fibroblastic sarcomas: a morphological and fluorescence in situ hybridization study.
Zreik RT; Carter JM; Sukov WR; Ahrens WA; Fritchie KJ; Montgomery EA; Weiss SW; Folpe AL
Hum Pathol; 2016 Jul; 53():14-24. PubMed ID: 26980036
[TBL] [Abstract][Full Text] [Related]
11. Recurrent PTBP1::MAML2 fusions in composite hemangioendothelioma with neuroendocrine differentiation: A report of two cases involving neck lymph nodes.
Dermawan JK; Westra WH; Antonescu CR
Genes Chromosomes Cancer; 2022 Apr; 61(4):187-193. PubMed ID: 34862698
[TBL] [Abstract][Full Text] [Related]
12. TGFBR3 and MGEA5 rearrangements in pleomorphic hyalinizing angiectatic tumors and the spectrum of related neoplasms.
Carter JM; Sukov WR; Montgomery E; Goldblum JR; Billings SD; Fritchie KJ; Folpe AL
Am J Surg Pathol; 2014 Sep; 38(9):1182-992. PubMed ID: 24705316
[TBL] [Abstract][Full Text] [Related]
13. Untying the Gordian knot of composite hemangioendothelioma: Discovery of novel fusions.
Linos K; Dermawan JK; Pulitzer M; Hameed M; Agaram NP; Agaimy A; Antonescu CR
Genes Chromosomes Cancer; 2024 Jan; 63(1):e23198. PubMed ID: 37658696
[TBL] [Abstract][Full Text] [Related]
14. Metaplastic thymoma: a distinctive thymic neoplasm characterized by YAP1-MAML2 gene fusions.
Vivero M; Davineni P; Nardi V; Chan JKC; Sholl LM
Mod Pathol; 2020 Apr; 33(4):560-565. PubMed ID: 31641231
[TBL] [Abstract][Full Text] [Related]
15. YAP1-TFE3-fused hemangioendothelioma: a multi-institutional clinicopathologic study of 24 genetically-confirmed cases.
Dermawan JK; Azzato EM; Billings SD; Fritchie KJ; Aubert S; Bahrami A; Barisella M; Baumhoer D; Blum V; Bode B; Aesif SW; Bovée JVMG; Dickson BC; van den Hout M; Lucas DR; Moch H; Oaxaca G; Righi A; Sciot R; Sumathi V; Yoshida A; Rubin BP
Mod Pathol; 2021 Dec; 34(12):2211-2221. PubMed ID: 34381186
[TBL] [Abstract][Full Text] [Related]
16. A Distinct Malignant Epithelioid Neoplasm With GLI1 Gene Rearrangements, Frequent S100 Protein Expression, and Metastatic Potential: Expanding the Spectrum of Pathologic Entities With ACTB/MALAT1/PTCH1-GLI1 Fusions.
Antonescu CR; Agaram NP; Sung YS; Zhang L; Swanson D; Dickson BC
Am J Surg Pathol; 2018 Apr; 42(4):553-560. PubMed ID: 29309307
[TBL] [Abstract][Full Text] [Related]
17. Loss of YAP1 C-terminus expression as an ancillary marker for metaplastic thymoma: a potential pitfall in detecting YAP1::MAML2 gene rearrangement.
Wang X; Liu LL; Li Q; Xia QY; Li R; Ye SB; Zhang RS; Fang R; Chen H; Wu N; Rao Q
Histopathology; 2023 Nov; 83(5):798-809. PubMed ID: 37565303
[TBL] [Abstract][Full Text] [Related]
18. Pseudoendocrine Sarcoma: Clinicopathologic Analysis of 23 Cases of a Distinctive Soft Tissue Neoplasm With Metastatic Potential, Recurrent CTNNB1 Mutations, and a Predilection for Truncal Locations.
Papke DJ; Dickson BC; Sholl L; Fletcher CDM
Am J Surg Pathol; 2022 Jan; 46(1):33-43. PubMed ID: 34081037
[TBL] [Abstract][Full Text] [Related]
19. MUC4 is a sensitive and extremely useful marker for sclerosing epithelioid fibrosarcoma: association with FUS gene rearrangement.
Doyle LA; Wang WL; Dal Cin P; Lopez-Terrada D; Mertens F; Lazar AJ; Fletcher CD; Hornick JL
Am J Surg Pathol; 2012 Oct; 36(10):1444-51. PubMed ID: 22982887
[TBL] [Abstract][Full Text] [Related]
20. NR1D1-rearranged soft tissue tumour: A clinicopathological and molecular analysis of four additional cases.
Yin T; Zhu P; Lao IW; Yu L; Bai Q; Zhou X; Wang J
Histopathology; 2024 Mar; 84(4):661-670. PubMed ID: 38084644
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
